140 related articles for article (PubMed ID: 9137129)
1. Decreased left frontal lobe N-acetylaspartate in schizophrenia.
Deicken RF; Zhou L; Corwin F; Vinogradov S; Weiner MW
Am J Psychiatry; 1997 May; 154(5):688-90. PubMed ID: 9137129
[TBL] [Abstract][Full Text] [Related]
2. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia.
Deicken RF; Johnson C; Eliaz Y; Schuff N
Am J Psychiatry; 2000 Apr; 157(4):644-7. PubMed ID: 10739431
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
Deicken RF; Zhou L; Schuff N; Weiner MW
Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
Deicken RF; Zhou L; Schuff N; Fein G; Weiner MW
Biol Psychiatry; 1998 Apr; 43(7):483-8. PubMed ID: 9547926
[TBL] [Abstract][Full Text] [Related]
5. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
Deicken RF; Pegues MP; Anzalone S; Feiwell R; Soher B
Am J Psychiatry; 2003 May; 160(5):873-82. PubMed ID: 12727690
[TBL] [Abstract][Full Text] [Related]
6. Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study.
Ende G; Braus DF; Walter S; Henn FA
Am J Psychiatry; 2001 Aug; 158(8):1314-6. PubMed ID: 11481168
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
8. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis.
Renshaw PF; Yurgelun-Todd DA; Tohen M; Gruber S; Cohen BM
Am J Psychiatry; 1995 Mar; 152(3):444-6. PubMed ID: 7864274
[TBL] [Abstract][Full Text] [Related]
9. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report.
Delamillieure P; Fernandez J; Constans JM; Brazo P; Benali K; Abadie P; Vasse T; Thibaut F; Courthéoux P; Petit M; Dollfus S
Am J Psychiatry; 2000 Apr; 157(4):641-3. PubMed ID: 10739430
[TBL] [Abstract][Full Text] [Related]
11. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
Szulc A; Galinska B; Tarasow E; Dzienis W; Kubas B; Konarzewska B; Walecki J; Alathiaki AS; Czernikiewicz A
Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
[TBL] [Abstract][Full Text] [Related]
12. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N
Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760
[TBL] [Abstract][Full Text] [Related]
13. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T.
Hetherington H; Kuzniecky R; Pan J; Mason G; Morawetz R; Harris C; Faught E; Vaughan T; Pohost G
Ann Neurol; 1995 Sep; 38(3):396-404. PubMed ID: 7668825
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
15. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging in patients with frontal lobe epilepsy.
Garcia PA; Laxer KD; van der Grond J; Hugg JW; Matson GB; Weiner MW
Ann Neurol; 1995 Feb; 37(2):279-81. PubMed ID: 7847871
[TBL] [Abstract][Full Text] [Related]
17. A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea.
Sarchielli P; Presciutti O; Alberti A; Tarducci R; Gobbi G; Galletti F; Costa C; Eusebi P; Calabresi P
Eur J Neurol; 2008 Oct; 15(10):1058-64. PubMed ID: 18717729
[TBL] [Abstract][Full Text] [Related]
18. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
19. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging.
Ende GR; Laxer KD; Knowlton RC; Matson GB; Schuff N; Fein G; Weiner MW
Radiology; 1997 Mar; 202(3):809-17. PubMed ID: 9051038
[TBL] [Abstract][Full Text] [Related]
20. Heritability heightens brain metabolite differences in schizophrenia.
Fukuzako H
J Neuropsychiatry Clin Neurosci; 2000; 12(1):95-7. PubMed ID: 10678520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
